Suppr超能文献

人血小板α2-肾上腺素能受体中作为配体结合位点的第四跨膜结构域的定位

Localization of the fourth membrane spanning domain as a ligand binding site in the human platelet alpha 2-adrenergic receptor.

作者信息

Matsui H, Lefkowitz R J, Caron M G, Regan J W

机构信息

Department of Medicine, Howard Hughes Medical Institute, Duke University Medical Center, Durham, North Carolina 27710.

出版信息

Biochemistry. 1989 May 2;28(9):4125-30. doi: 10.1021/bi00435a075.

Abstract

The human platelet alpha 2-adrenergic receptor is an integral membrane protein which binds epinephrine. The gene for this receptor has been cloned, and the primary structure is thus known [Kobilka et al. (1987) Science 238, 650-656]. A model of its secondary structure predicts that the receptor has seven transmembrane spanning domains. By covalent labeling and peptide mapping, we have identified a region of the receptor that is directly involved with ligand binding. Partially purified preparations of the receptor were covalently radiolabeled with either of two specific photoaffinity ligands: [3H]SKF 102229 (an antagonist) or p-azido[3H]clonidine (an agonist). The radiolabeled receptors were then digested with specific endopeptidases, and peptides containing the covalently bound radioligands were identified. Lysylendopeptidase treatment of [3H]SKF 102229 labeled receptor yielded one peptide of Mr 2400 as the product of a complete digest. Endopeptidase Arg-C gave a labeled peptide of Mr 4000, which was further digested to the Mr 2400 peptide by additional treatment with lysylendopeptidase. Using p-azido[3H]clonidine-labeled receptor, a similar Mr 2400 peptide was obtained by lysylendopeptidase cleavage. This Mr 2400 peptide corresponds to the fourth transmembrane spanning domain of the receptor. These data suggest that this region forms part of the ligand binding domain of the human platelet alpha 2-adrenergic receptor.

摘要

人血小板α2 - 肾上腺素能受体是一种结合肾上腺素的整合膜蛋白。该受体的基因已被克隆,其一级结构因而已知[科比尔卡等人(1987年)《科学》238卷,650 - 656页]。其二级结构模型预测该受体具有七个跨膜结构域。通过共价标记和肽图谱分析,我们确定了受体中直接参与配体结合的一个区域。受体的部分纯化制剂用两种特异性光亲和配体之一进行共价放射性标记:[3H]SKF 102229(一种拮抗剂)或对叠氮基[3H]可乐定(一种激动剂)。然后用特异性内肽酶消化放射性标记的受体,并鉴定含有共价结合放射性配体的肽段。用赖氨酰内肽酶处理[3H]SKF 102229标记的受体,完全消化后产生一个分子量为2400的肽段作为产物。内肽酶Arg - C产生一个分子量为4000的标记肽段,用赖氨酰内肽酶进一步处理后将其消化为分子量为2400的肽段。使用对叠氮基[3H]可乐定标记的受体,通过赖氨酰内肽酶切割得到一个类似的分子量为2400的肽段。这个分子量为2400的肽段对应于受体的第四个跨膜结构域。这些数据表明该区域构成了人血小板α2 - 肾上腺素能受体配体结合结构域的一部分。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验